SXTC
NASDAQ · Pharmaceuticals
China Sxt Pharmaceuticals In
$2.48
+0.09 (+3.77%)
Open$2.40
Previous Close$2.39
Day High$2.52
Day Low$2.33
52W High$1,046.98
52W Low—
Volume—
Avg Volume227.7K
Market Cap85.23M
P/E Ratio—
EPS$-161.77
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.01B | 8.01B | 998.7K |
| Net Income | -13,304,443,863 | -13,686,134,960 | 158.4K |
| Profit Margin | -189.8% | -180.3% | 15.9% |
| EBITDA | -10,492,533,287 | -11,393,195,362 | 317.7K |
| Free Cash Flow | — | — | 143.5K |
| Rev Growth | -12.5% | -12.5% | +6.7% |
| Debt/Equity | 0.05 | 0.05 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |